Roughly 15 percent of people of European descent are Rh negative, but that figure shifts dramatically depending on ancestry. In parts of sub-Saharan Africa and East Asia, the rate drops below 1 percent, while among the Basque population of Spain and France it climbs far higher than anywhere else on Earth. The global picture is less a single number and more a patchwork shaped by migration, genetics, and possibly chance.
The Numbers by Region
If you are of European background, the ballpark figure you will see most often is about 15 percent Rh negative. That number comes from decades of blood-bank data across Western Europe and populations of European descent in the Americas and Australia. Within Europe the rate varies: parts of Spain, France, and the British Isles tend to sit at the higher end, while eastern and southern European populations are somewhat lower.
The Basque people are an outlier. Genetic studies have found that the allele responsible for Rh-negative status reaches a frequency of about 47 percent among Basques, which translates to a much larger share of the population actually testing Rh negative than in any other well-studied group.1PubMed Central. Sequence diversity of the Rh blood group system in Basques Why the Basques carry the deletion at such high rates has been debated for decades. Their geographic and linguistic isolation in the Pyrenees probably allowed the variant to drift upward without being diluted by gene flow from surrounding populations.
Move to South Asia, and the picture changes. A large multicenter study of blood donors across five regions of India found that only about 5.4 percent were Rh negative, with regional variation between roughly 4.8 and 7 percent.2PubMed Central. ABO and Rh (D) group distribution and gene frequency; the first multicentric study in India In East Asian populations the rate is even lower, often below 1 percent. Indigenous populations of the Americas and Australia also tend to have very low Rh-negative frequencies, in some groups approaching zero. Sub-Saharan African populations generally fall somewhere in the range of 1 to 5 percent, depending on the specific community.
All of this means there is no single “world average” that captures the reality very well. If you forced one, it would land somewhere around 5 to 8 percent of all humans, but that number hides enormous variation. For practical purposes, where you or your ancestors come from matters far more than any global average.
Why the Rates Differ So Much
Being Rh negative is not caused by the same genetic event in every population. In people of European descent, the most common cause is a wholesale deletion of the RHD gene. The gene simply is not there. In Europeans, the haplotype carrying this deletion has been measured at a frequency of about 40 percent, which, because you need two copies of the deletion to actually type as Rh negative, produces roughly the 15 percent rate seen in blood banks.3Blood. RHD gene deletion occurred in the Rhesus box
In people of African descent, a different mechanism often produces the same blood-typing result. Instead of the gene being missing, many Rh-negative Africans carry a pseudogene: an RHD gene that is physically present in their DNA but has been broken by mutations. This pseudogene, called RHDψ, contains a small duplicated stretch in one segment and stop signals that prevent the gene from producing a working protein.4PubMed. The presence of an RHD pseudogene containing a 37 base pair duplication and a nonsense mutation in africans with the Rh D-negative blood group phenotype A study of Rh-negative individuals of African origin in Brazil found that about 14 percent carried this pseudogene variant.5Brazilian Journal of Medical and Biological Research. Presence of the RHD pseudogene and the hybrid RHD-CE-Ds gene in Brazilians with the D-negative phenotype
The practical result for a blood bank is the same: these individuals type as Rh negative and should receive Rh-negative blood. But the distinction matters for genetic testing, prenatal screening, and understanding how the trait spread through different populations. When researchers try to predict Rh status from DNA rather than from a standard blood test, they need to know which variant to look for.
The Gray Zone Between Positive and Negative
Not everyone sorts neatly into “positive” or “negative.” Somewhere between 0.2 and 1 percent of routine Rh-D blood typings produce what is called a weak D result, where the D antigen is present on red blood cells but in much smaller amounts than normal.6PubMed Central. Serological weak D phenotypes: a review and guidance for interpreting the RhD blood type using the RhD blood type using the RHD genotype Weak D is not a single condition. Dozens of different genetic variants can produce it, each resulting in a different density of D antigen on the cell surface, ranging from a few dozen molecules per cell up to a few thousand.7Blood. Weak D alleles express distinct phenotypes
Why does this matter? If you are a blood donor with weak D, you might be typed as Rh positive by one lab and Rh negative by another, depending on the sensitivity of the test used. For transfusion recipients, the stakes are slightly different. The most common weak D variants (types 1, 2, and 3 in the research literature) are generally considered safe to treat as Rh positive, meaning those individuals can receive Rh-positive blood without trouble. Rarer weak D variants, however, can behave more like partial D antigens, where the immune system might still mount a response against standard D-positive blood. The clinical guidelines have evolved over time as genotyping has become more accessible, and in many transfusion services, patients with an unclear Rh result can now get a DNA-based test to determine exactly which variant they carry.
When Rh Status Has No Rh at All
At the far extreme of rarity sits Rh-null, a phenotype in which all Rh antigens are absent from red blood cells. This is not just being Rh-D negative. People with Rh-null lack D, C, c, E, and e antigens entirely. Fewer than 50 individuals worldwide have ever been documented with this blood type, earning it the nickname “golden blood” in transfusion medicine circles.
Rh-null matters because the Rh proteins do more than just serve as blood-type markers. They contribute to the structural integrity of the red blood cell membrane. Without them, red cells become abnormally shaped and fragile, leading to chronic hemolytic anemia of varying severity.8PubMed. Rhnull: a rare blood group phenotype People with this phenotype face a double bind: they can only safely receive Rh-null blood, which essentially means their own stored blood or that of the handful of other Rh-null individuals willing and able to donate. Some Rh-null individuals have donated blood that has been shipped internationally for specific patients, making them among the most valuable blood donors in the world even as their own condition causes ongoing health problems.
What Rh Proteins Actually Do on Red Blood Cells
The reason Rh-null causes health problems hints at a broader question: why do red blood cells carry Rh proteins in the first place? These proteins are not just passive identity tags. Research has shown that they belong to an ancient family of membrane proteins involved in ammonia transport. In the red blood cell membrane, Rh proteins form a complex that anchors to the cell’s internal skeleton, helping maintain the cell’s shape and flexibility.9PubMed Central. The structure and function of the Rh antigen complex Related Rh family proteins in the kidneys and liver also appear to facilitate the movement of ammonia and related molecules across cell membranes.10PubMed. Rh proteins: key structural and functional components of the red cell membrane
For most people, being Rh negative means lacking the D protein specifically but still having the closely related C/c and E/e proteins. That is enough to preserve red cell structure and function. It is only when all Rh proteins are absent, as in Rh-null, that red cells fall apart prematurely. This is a useful reminder that “Rh negative” in everyday medical parlance refers only to the D antigen and is not the same as lacking all Rh-related proteins.
Pregnancy and Why Rh-Negative Status Still Causes Harm
The most well-known medical consequence of being Rh negative is the risk during pregnancy. When an Rh-negative mother carries an Rh-positive baby, small amounts of fetal blood can cross into her circulation, especially during delivery. Her immune system may then produce antibodies against the D antigen. In a first pregnancy, this rarely causes problems. But in subsequent pregnancies with Rh-positive babies, those antibodies can cross the placenta and attack the baby’s red blood cells, causing hemolytic disease of the fetus and newborn.
The solution, developed in the 1960s, is an injection of anti-D immunoglobulin (commonly known by brand names like RhoGAM) given to Rh-negative mothers during pregnancy and after delivery. It works by clearing any fetal Rh-positive cells from the mother’s circulation before her immune system mounts a lasting response. In wealthy countries with universal prenatal care, this treatment has made severe hemolytic disease rare.
Globally, though, the picture is grimmer. Estimates suggest that roughly 13 million doses of anti-D immunoglobulin would be needed each year worldwide to prevent sensitization both during pregnancy and after delivery. Fewer than 4 million doses are actually administered, and the shortfall is concentrated in low- and middle-income countries.11PLOS ONE. Hemolytic disease of the fetus and newborn due to Rh(D) incompatibility: A preventable disease that still produces significant morbidity and mortality in children More than 2.5 million additional annual doses are needed outside high-income countries just to achieve post-delivery coverage alone. In populations where Rh-negative rates are low, the disease is correspondingly uncommon, but it is not absent. Even at a 5 percent Rh-negative rate, a large country can produce tens of thousands of at-risk pregnancies each year.
Blood Supply and Transfusion Logistics
Rh-negative blood, especially O-negative, occupies a special place in emergency medicine. O-negative red cells can be given to virtually any patient in an emergency when there is no time to determine their blood type. This makes O-negative units disproportionately valuable relative to how common they are. In populations of European descent, O-negative donors make up about 7 to 8 percent of the population, but demand for their blood routinely outstrips supply because it is the default for trauma, emergency surgery, and neonatal transfusion.
Blood banks have to balance two conflicting pressures. Holding O-negative units in reserve for emergencies means they sometimes expire before use, which is wasteful. Using them for routine transfusions of O-negative patients depletes the emergency stock. Research into blood-type substitution policies, where a compatible but not identical unit is used when a patient’s exact type is unavailable, has shown that current hospital practices often create imbalances in O-negative supply and demand.12Production and Operations Management. Substitution or Emergency Order? Averting O-Negative Blood Shortages In countries with low overall Rh-negative prevalence, the supply challenge is even more acute: fewer donors can provide Rh-negative blood, but the clinical need for it in emergencies is just as real.
If you are Rh negative and have ever been encouraged to donate blood, this is why. Your blood is not just useful for other Rh-negative patients; it is the universal fallback when lives are on the line and there is no time for typing.
The Evolutionary Puzzle
Here is something that has puzzled geneticists for decades. Before modern medicine, Rh-negative mothers who carried Rh-positive babies faced a real risk of losing those babies to hemolytic disease, especially in second and later pregnancies. This should have been a powerful force pushing the Rh-negative variant out of the population over thousands of generations. And yet, in European populations, the deletion that causes Rh-negative status sits at a frequency of roughly 40 percent of chromosomes, which is surprisingly high for a variant that used to kill babies.13PubMed Central. Evolutionary genetics of the human Rh blood group system
One hypothesis was that the deletion might confer some hidden health advantage that counterbalanced the pregnancy risk, similar to how the sickle cell trait persists because it protects against malaria. Researchers have tested this idea using modern genomic tools and population data. The results have been mostly negative: there is no clear signature of positive natural selection acting on the RHD deletion in European genomes.13PubMed Central. Evolutionary genetics of the human Rh blood group system The current best explanation is less dramatic. The deletion may have risen to intermediate frequency through genetic drift or a founder effect early in European population history. Once it reached roughly 50 percent of chromosomes, the selection pressure against it becomes mathematically weak, because at that frequency a large proportion of pregnancies are Rh-compatible anyway. So the variant just stayed put, maintained by a balance between weak negative selection and random drift.
This is a somewhat unsatisfying answer, and it is entirely possible that a more complex selective story is at work but too old or too subtle for current methods to detect. For now, the honest summary is that we do not fully understand why the trait is so common in Europeans.
Rh Status and Toxoplasma
An unexpected line of research has connected Rh status to the effects of infection with Toxoplasma gondii, the parasite best known for its association with cats and undercooked meat. Toxoplasma infects a substantial fraction of the world’s population and is usually considered harmless in healthy adults, but it appears to cause subtle changes in behavior and physiology that researchers have been cataloging for years.
Several studies from a Czech research group have reported that Rh-negative individuals who are infected with Toxoplasma show different patterns of effects compared to Rh-positive infected individuals. In tests of physical performance, for instance, Toxoplasma-infected Rh-negative subjects performed worse on measures of grip strength and endurance compared to uninfected Rh-negative subjects, while Rh-positive infected subjects sometimes showed the opposite pattern, particularly men.14PubMed Central. Lower performance of Toxoplasma-infected, Rh-negative subjects in the weight-holding and hand-grip tests Earlier work from the same group has suggested that Rh-negative status might amplify the behavioral effects of Toxoplasma infection more broadly, including reaction-time changes that could affect driving safety.
This research is intriguing but comes with significant caveats. Most of the findings come from a single research group, many of the observed effects are small, and the biological mechanism connecting Rh proteins on red blood cells to the neurological effects of a brain parasite remains speculative. It is far too early to say that being Rh negative makes Toxoplasma infection meaningfully more dangerous. But the work illustrates a broader point: blood-group antigens are not just labels for transfusion purposes. They are functional molecules, and their presence or absence can interact with the rest of human biology in ways we are still uncovering.
Common Misconceptions About Rh-Negative Blood
A surprising amount of misinformation circulates online about Rh-negative blood. Some of the more popular claims include the idea that Rh-negative individuals have alien ancestry, that they share special personality traits, or that their blood type is connected to specific royal bloodlines. None of these claims have any scientific support. The RHD gene deletion is a well-characterized genetic event whose distribution tracks with known human migration patterns, not with anything mysterious.
A more plausible-sounding but still misleading claim is that Rh-negative blood is universally rare. As the regional data show, it depends entirely on the population. In a hospital in Dublin, about 15 percent of patients will be Rh negative. In a hospital in Tokyo, it might be fewer than 1 in 200. Calling it “rare” without specifying the population is not especially useful.
Another common misunderstanding is that Rh-negative people can only receive Rh-negative blood. For red blood cell transfusions, this is essentially true, though in life-threatening emergencies Rh-positive blood has been given to Rh-negative patients when no alternative was available (with the understanding that the recipient may develop anti-D antibodies afterward). For plasma and platelet transfusions, however, the Rh rules are less strict because those blood products do not normally carry significant amounts of the D antigen. The distinction between what matters for red cells versus plasma is often lost in popular discussions of blood type.
Finally, the idea that being Rh negative is itself a health condition or disadvantage is overstated. Outside of pregnancy, being Rh negative has no known direct health consequences. You do not have weaker immunity, higher cancer risk, or different life expectancy because of your Rh status. The only well-established medical concern is the pregnancy scenario, and that is now preventable with standard prenatal care in most healthcare systems.